CDI for amyloid beta (Aß) and immunohistochemistry for Aß, alpha-synuclein, TDP-43, and FUS excluded coexistent proteinopathies and other comorbidities [22, 56, 83] (Supplementary Table 2, supplementary Fig. 3). The gene discussed is TARDBP; the disease is proteostasis deficiencies.